100 related articles for article (PubMed ID: 12657241)
1. Expression of Id2 mRNA in neuroblastoma and normal ganglion.
Sato Y; Kobayashi Y; Sasaki H; Toyama T; Kondo S; Kiriyama M; Fujii Y
Eur J Surg Oncol; 2003 Apr; 29(3):284-7. PubMed ID: 12657241
[TBL] [Abstract][Full Text] [Related]
2. ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas.
Wang Q; Hii G; Shusterman S; Mosse Y; Winter CL; Guo C; Zhao H; Rappaport E; Hogarty MD; Maris JM
Cancer Res; 2003 Apr; 63(7):1631-5. PubMed ID: 12670915
[TBL] [Abstract][Full Text] [Related]
3. Expression profiles and clinical relationships of ID2, CDKN1B, and CDKN2A in primary neuroblastoma.
Gebauer S; Yu AL; Omura-Minamisawa M; Batova A; Diccianni MB
Genes Chromosomes Cancer; 2004 Dec; 41(4):297-308. PubMed ID: 15390183
[TBL] [Abstract][Full Text] [Related]
4. ID2 expression in neuroblastoma does not correlate to MYCN levels and lacks prognostic value.
Vandesompele J; Edsjö A; De Preter K; Axelson H; Speleman F; Påhlman S
Oncogene; 2003 Jan; 22(3):456-60. PubMed ID: 12545167
[TBL] [Abstract][Full Text] [Related]
5. Id2 is critical for cellular proliferation and is the oncogenic effector of N-myc in human neuroblastoma.
Lasorella A; Boldrini R; Dominici C; Donfrancesco A; Yokota Y; Inserra A; Iavarone A
Cancer Res; 2002 Jan; 62(1):301-6. PubMed ID: 11782392
[TBL] [Abstract][Full Text] [Related]
6. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins.
Lasorella A; Noseda M; Beyna M; Yokota Y; Iavarone A
Nature; 2000 Oct; 407(6804):592-8. PubMed ID: 11034201
[TBL] [Abstract][Full Text] [Related]
7. Induction of ID2 expression by hypoxia-inducible factor-1: a role in dedifferentiation of hypoxic neuroblastoma cells.
Löfstedt T; Jögi A; Sigvardsson M; Gradin K; Poellinger L; Påhlman S; Axelson H
J Biol Chem; 2004 Sep; 279(38):39223-31. PubMed ID: 15252039
[TBL] [Abstract][Full Text] [Related]
8. Expression of the cdc25B mRNA correlated with that of N-myc in neuroblastoma.
Sato Y; Sasaki H; Kondo S; Fukai I; Kiriyama M; Yamakawa Y; Fujii Y
Jpn J Clin Oncol; 2001 Sep; 31(9):428-31. PubMed ID: 11689596
[TBL] [Abstract][Full Text] [Related]
9. Effect of 20-epi-1alpha,25-dihydroxyvitamin D3 on the proliferation of human neuroblastoma: role of cell cycle regulators and the Myc-Id2 pathway.
Gumireddy K; Ikegaki N; Phillips PC; Sutton LN; Reddy CD
Biochem Pharmacol; 2003 Jun; 65(12):1943-55. PubMed ID: 12787874
[TBL] [Abstract][Full Text] [Related]
10. The helix-loop-helix protein Id2 is expressed differentially and induced by myc in T-cell lymphomas.
Cotta CV; Leventaki V; Atsaves V; Vidaki A; Schlette E; Jones D; Medeiros LJ; Rassidakis GZ
Cancer; 2008 Feb; 112(3):552-61. PubMed ID: 18085637
[TBL] [Abstract][Full Text] [Related]
11. Id2 protein is selectively upregulated by UVB in primary, but not in immortalized human keratinocytes and inhibits differentiation.
Simbulan-Rosenthal CM; Trabosh V; Velarde A; Chou FP; Daher A; Tenzin F; Tokino T; Rosenthal DS
Oncogene; 2005 Aug; 24(35):5443-58. PubMed ID: 16007217
[TBL] [Abstract][Full Text] [Related]
12. Id2 mediates tumor initiation, proliferation, and angiogenesis in Rb mutant mice.
Lasorella A; Rothschild G; Yokota Y; Russell RG; Iavarone A
Mol Cell Biol; 2005 May; 25(9):3563-74. PubMed ID: 15831462
[TBL] [Abstract][Full Text] [Related]
13. Expression of Id2 and Id3 mRNA in human lymphocytes.
Ishiguro A; Spirin K; Shiohara M; Tobler A; Norton JD; Rigolet M; Shimbo T; Koeffler HP
Leuk Res; 1995 Dec; 19(12):989-96. PubMed ID: 8632670
[TBL] [Abstract][Full Text] [Related]
14. Expression of the prothymosin alpha mRNA correlated with that of N-myc in neuroblastoma.
Sasaki H; Sato Y; Kondo S; Fukai I; Kiriyama M; Yamakawa Y; Fujii Y
Cancer Lett; 2001 Jul; 168(2):191-5. PubMed ID: 11403924
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of MYCN and ID2 overexpression in neuroblastoma.
Alaminos M; Gerald WL; Cheung NK
Pediatr Blood Cancer; 2005 Dec; 45(7):909-15. PubMed ID: 16047351
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin receptor type 2 gene expression in neuroblastoma, measured by competitive RT-PCR, is related to patient survival and to somatostatin receptor imaging by indium -111-pentetreotide.
Orlando C; Raggi CC; Bagnoni L; Sestini R; Briganti V; La Cava G; Bernini G; Tonini GP; Pazzagli M; Serio M; Maggi M
Med Pediatr Oncol; 2001 Jan; 36(1):224-6. PubMed ID: 11464890
[TBL] [Abstract][Full Text] [Related]
17. The basic helix-loop-helix transcription factor dHAND, a marker gene for the developing human sympathetic nervous system, is expressed in both high- and low-stage neuroblastomas.
Gestblom C; Grynfeld A; Ora I; Ortoft E; Larsson C; Axelson H; Sandstedt B; Cserjesi P; Olson EN; Påhlman S
Lab Invest; 1999 Jan; 79(1):67-79. PubMed ID: 9952112
[TBL] [Abstract][Full Text] [Related]
18. [Id2, a go-between in the Myc-Rb pair].
Bénard J; Raguenez G; Douc-Rasy S
Bull Cancer; 2000 Dec; 87(12):877-80. PubMed ID: 11174116
[No Abstract] [Full Text] [Related]
19. Id2 is dispensable for myc-induced lymphomagenesis.
Nilsson JA; Nilsson LM; Keller U; Yokota Y; Boyd K; Cleveland JL
Cancer Res; 2004 Oct; 64(20):7296-301. PubMed ID: 15492249
[TBL] [Abstract][Full Text] [Related]
20. Expression of the periostin mRNA level in neuroblastoma.
Sasaki H; Sato Y; Kondo S; Fukai I; Kiriyama M; Yamakawa Y; Fuji Y
J Pediatr Surg; 2002 Sep; 37(9):1293-7. PubMed ID: 12194119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
